Publications by authors named "Lars Damen"

Claim this Profile
S
Safety Assessment of Butyric Acid-Rich Triglyceride Oil: A Novel Palatable Formulation of Butyrate for the Pediatric Population.
John A Watson, Sophie Nutten, Angelique Groot, Roy Hoffmans, Lars Damen

J Appl Toxicol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of heparin-binding amino acid residues in antibody HS4C3 with the potential to design antibodies against heparan sulfate domains.
Lars A A Damen, Thao P Bui, Thierry van Wessel, Yong Li, Bart F Straten

Glycobiology· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic background determines renal response to chronic lithium treatment in female mice.
Theun de Groot, Rosalinda Doty, Lars Damen, Ruben Baumgarten, Steffi Bressers

Physiol Genomics· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Construction and evaluation of an antibody phage display library targeting heparan sulfate.
Lars A A Damen, Els M A van de Westerlo, Elly M M Versteeg, Thierry van Wessel, Willeke F Daamen

Glycoconj J· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short-Term Hypoxia Dampens Inflammation in vivo via Enhanced Adenosine Release and Adenosine 2B Receptor Stimulation.
Dorien Kiers, Ben Wielockx, Esther Peters, Lucas T van Eijk, Jelle Gerretsen, Lars Damen

EBioMedicine· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lithium reduces blood glucose levels, but aggravates albuminuria in BTBR-ob/ob mice.
Theun de Groot, Lars Damen, Leanne Kosse, Mohammad Alsady, Rosalinda Doty

PLoS One· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis